| Oct'19 | Jul'19 | Oct'18 | Jul'18 | |||
|---|---|---|---|---|---|---|
Revenue: | ||||||
Revenues from contract with customer | ||||||
32,843 | 30,816 | 24,756 | 24,778 | |||
Expenses: | ||||||
Cost of revenue (excluding depreciation and amortization) | ||||||
4,388 | 4,210 | 3,805 | 3,603 | |||
Payment processing expense | ||||||
6,902 | 7,100 | 5,393 | 5,326 | |||
Sales and marketing | ||||||
8,348 | 8,120 | 7,195 | 6,528 | |||
Research and development | ||||||
4,774 | 4,689 | 3,856 | 3,178 | |||
General and administrative | ||||||
7,184 | 7,420 | 4,540 | 4,649 | |||
Depreciation | ||||||
2,153 | 2,136 | 1,966 | 1,777 | |||
Amortization | ||||||
1,325 | 1,279 | 1,037 | 962 | |||
Total expenses | ||||||
35,074 | 34,956 | 27,792 | 26,027 | |||
Operating loss | ||||||
-2,231 | -4,140 | -3,036 | -1,248 | |||
Other income (expense) | ||||||
77 | 327 | 203 | 138 | |||
Change in fair value of warrant liability | ||||||
0 | 2,883 | 611 | 593 | |||
Interest income (expense) | ||||||
-219 | -745 | -728 | -883 | |||
Total other income (expense) | ||||||
-142 | -3,301 | -1,136 | -1,338 | |||
Loss before benefit from (provision for) income taxes | ||||||
-2,373 | -7,442 | -4,172 | -2,586 | |||
Benefit from (provision for) income taxes | ||||||
64 | 51 | 0 | 0 | |||
Net loss | ||||||
-2,437 | -7,493 | -4,172 | -2,586 | |||
Preferred stock dividends paid | ||||||
0 | 14,955 | 0 | 0 | |||
Accretion of redeemable preferred stock | ||||||
0 | 48,311 | 9,236 | 9,236 | |||
Net loss attributable to common stockholders, basic and diluted | ||||||
-2,437 | -70,760 | -13,408 | -11,823 | |||
Net loss per share attributable to common stockholders, basic and diluted (in usd per share) | ||||||
-0.07 | -10.42 | -7.02 | -6.66 | |||
Weighted-average common shares outstanding, basic and diluted (in shares) | ||||||
35,790 | 6,793 | 1,909 | 1,776 | |||
Subscription And Related Services [Member] | ||||||
Revenues | ||||||
14,606 | 14,003 | 10,929 | 10,459 | |||
Payment processing fees | ||||||
Revenues from contract with customer | ||||||
11,559 | 11,664 | 9,073 | 9,173 | |||
Life sciences | ||||||
Revenues from contract with customer | ||||||
6,678 | 5,147 | 4,754 | 5,145 | |||